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1. Introduction 
The progress in the molecular pharmacology area continues to maintain a very alert rhythm 
at the beginning of the 3rd millennium. The volume of information accumulated in this area, 
with boundaries constantly expanding, as modern technology applied in current research 
which allows linking the imbalances manifested in the central nervous system metabolism 
with its various pathologies.  
The neurons represent unique anatomical fractions, with the ability to forward the information 
in a network system, which justifies the experience-dependent mechanisms such as 
memorization, learning or consciousness. In order to fulfill these functions, the neurons are, 
structurally and functionally polarized. This aspect is obvious in their tripartite composition: 
cell body, axon and dendrites. While the body comprises the biosynthesis structure (nucleus, 
ribosomes, endoplasmic reticulum, Golgi apparatus and mitochondria for energy storage), the 
axon is equipped with molecular and under-cellular components for the propagation of the 
action potential from the cell body to distant targets, the dendrites represent a set of branched 
endings which prolong from the cell body and have as result an increase of it, in order to 
receive the signal. The structural connections for the signal transmission are the basis of the 
neural architecture. Inside the mature nervous system, normally, the neural circuit (neuro-
architecture) supports adaptive changes. Inside an old synapses neural cells can involute (until 
their disappearance), with simultaneous formation of new branches (new neuritis) which will 
establish new synapses. These changes in the neurotic and synaptic architecture prove the 
great plasticity (capacity) of the nervous system to adapt to the environmental conditions. 
Today we consider that there are two major intracellular classes of factors (signals) which 
adjust the neuronal development and adaptation: growth factors (the growth factor - 
fibroblasts, the ciliary neutrophil factor, etc.) and the neurotransmitters factors (dopamine, 
serotonin, acetylcholine, glutamate, etc.). The loss of balance between the two systems of 
factors leads to the development of the pathological states.  
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The investigation of the central nervous system remains a fascinating field; it constitutes an 
inexhaustible source of new discoveries. The diversity of human nature and the uniqueness 
of the individual cerebral architecture lead to the exploration in this area on very subtle and 
difficult ways to analyze.   
The individuality cell status, immune, genetic, etc., raised many questions, over time, and 
opened gates for new researches on human polytypism. Thus, under the action of identical 
factors, physical and emotional, the human beings develop different physiological, 
behavioral and emotional responses. This phenomenon was called polytypism. The 
phenomenon was inferred in 1980 by Rosenman RH who described, for the first time, the 
adrenergic behavioral type (type A).Lately, in the 1990s there was identified and 
described the opioid type (type O), the “non-A” type, opposite to the adrenergic type 
from the behavior point of view, and in 2000 the behavioral oncology has introduced the 
concept of C type, with genetic predisposition to the development of the biopsychosocial 
cancer. 
In this context, the individualization of pharmacotherapy based on the 
psychoneuroendocrine typology, could be an important step for a specific medication, 
targeted and with fewer side effects. For this purpose, the molecular pharmacology 
researches in the world should bring evidences regarding the cellular, molecular processes 
which are the base of the pathophysiology for different psychoneuroendocrine types.  
2. The psychoneuroendocrine behavior typology, factor of the biological and 
pharmacological variability 
The differentiation of the adrenergic typology was first realized in 1978 by RH 
Rosenman, by describing some specific behavioral characteristics that predispose it to 
the emergence and the development of psychiatric and cardiovascular diseases: 
competitiveness, sharp ambition, continuous involvement in multiple and diverse 
activities, with a sense of haste and time urgency, irritability, impulsivity, reduced 
ability to disconnect and relaxation. Later, in the 1990s there was identified and 
described the “non-A” type, opposite to the adrenergics from the behavior point of view. 
Presently it is defined as the opioid type (O type), with the psychoneuroendocrine 
predominance of the endogenous opioid system. It has the following characteristics: 
defensive, calm, relaxed, non-aggressive, introverted, resistant to pain, but with 
predisposition to the hiperalgia post-stress syndrome. 
The specialty literature describes several methods for identifying the A type of behavior in 
humans:  
 The structured interview (SI), developed by Rosenman and Friedman  (in 1978), in 
studies on mid-range employees. This interview contained a series of questions and 
followed: the volume of voice, the speed of response, the rhythm of the words, the 
latency of the responses, the gestures, the mimics, and the signs of hostility.  
 Self-assessment methods, where the specialty literature includes:  
 Jenkins Questionnaire (JAS) contained 52 questions, similar with the structured 
interview and was developed by Jenkins in collaboration with Rosenman and 
Friedman;  
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 Framingham Scale contained 10 questions about the time urgency, the 
competitiveness and the motivation to work, the strong need to excel, the measures 
in which it feels dominated, the speed of eating;  
 Bortner grading scale consisted of 14 questions and hass been extensively used in 
the European epidemiological studies;  
 Special Scale useful for the identification of some particular features of A type (e.g. 
Interpersonal Communication).  
3. Clinical and murine studies for investigating the adrenergic behavioral 
psychoneuroendocrine typology 
The specialty literature describes numerous clinical and murine studies that have attempted 
to correlate the behavioral characteristics of A type with different physiological and 
biochemical parameters responsible for the onset of the psychiatric and cardiovascular 
diseases.  
3.1 The cardiovascular reactivity  
Numerous clinical studies (Appleton K.M) have been performed to correlate the 
characteristic features of A type with the cardiovascular responses, especially in stress. 
Thus, after the differentiation of individuals taken into study in groups of type A and type B 
(based on the Structured Interview validated by Rosenman, they were submitted to stressful 
situations (e.g. mental arithmetic exercises or unpleasant images displayed on a screen). 
They determined the following parameters: electrocardiogram, blood pressure, heart rate, 
peripheral vasoconstriction (the fingers). All studies have shown for the A type subjects 
exaggerated cardiovascular responses, in stress conditions.  
Jones et al. investigated the variability of blood pressure in type A, related to the pleasure of 
victory. Thus, it was found that both victory and defeat, determined significantly higher 
cardiovascular responses for type A versus type B. The type A winners were distinguished 
from all other subjects by maintaining high levels of blood pressure and the type A losers 
have lost interest in competition.  
It was also pursued in a study of 81 volunteers (published by Meesters C.M.G), the 
associatian between hostility and the risk of death by acute myocardial infarction. For 
comparison there were used a lot of subjects which had suffered a first myocardial 
infarction and a group which had no previous event. Following this study there was shown 
that the hostility was significantly associated with the risk of myocardial infarction, in 
people aged over 50 years.  
In a clinical study conducted in the U.S.A., there was studied the generally individual 
sympathetic tonus of the type A individuals versus the ones of type B, by determining the 
pupil’s diameter and also the platelet catecholamine concentrations (Powell L.H).  
The study was conducted on 112 volunteers, differentiated on the basis of the Structured 
Interview. The individuals involved in the behavioral A typology were evidenced by a 
significantly higher adrenergic tone than on type B: higher pupillary diameter and high 
concentrations of platelet adrenaline.   
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In a study conducted in Canada there were followed, at individuals of type A, variations of 
the cardiovascular parameters after the administration, in bolus, a 50μg CCK-4 
(cholecystokinin-tetrapeptid). This compound, administered in the shown manner, has the 
ability to produce symptoms of panic (panicogen agent). The variations of the heart rate, 
after the administration of CCK-4, were significantly higher in type A versus type B (Le 
Melledo J.M).  
3.2 Pain sensitivity (endogenous analgesia) 
Clinical studies (Cristea A) were conducted for evaluating analgesia and also the post-stress 
syndrome, in acute and chronic stress in type O compared with type A. Data reported in 
literature evoked the following: 
 the basal pain sensitivity was significantly different in the two psychoneuroendocrine 
types (hypersensitivity to pain for type A, compared with a painful hypo-sensibility 
in type O); 
 in chronic stress, the opioid becomes hypersensitive to pain and the adrenergic 
manifests depressive symptomatology.  
3.3 Nervous behavior of types A and O 
In a psychiatric hospital from Norway (Haukeland University Hospital) a clinical trial was 
conducted on 99 patients admitted for behavioral disturbances associated with depression 
(Oedegaard K.J). The patients were distinguished in lots A and B, based on the Jenkins 
questionnaire and there was followed the frequency of unipolar depression, bipolar 
depression and behavior depending on the type of migraine. The results of the study 
showed the following:  
 the patients classified in the behavioral adrenergic typology were diagnosed with 
bipolar depression (in proportion of 65%);  
 type A is characterized by a ciclotimic temper;  
 the frequency of the migraine crisis was not significantly correlated with either type A 
or type B.  
Comparative experimental studies have been conducted on animal behavior of type A and 
O, in pharmacological tests: the actometry test (for investigation the spontaneous motor 
activity), the platform test, the inclined plane test and the plate with holes test (to research 
the evasion-investigation behavior), the cross-maze test (for investigating the anxiety). These 
tests were performed on animal communities distributed on both psychoneuroendocrine 
typology and on gender (male of type A and male of type O, respectively on female of type 
A and O). The motor activity and the behavior of investigation were significantly higher in 
type A, the best results being recorded for the male animal communities (Cristea A). The 
cross-maze test revealed a significant predisposition to anxiety of the adrenergic type, 
regardless the gender.  
Some authors speculated that the pathophysiological hallmark of type A individuals is the 
hyperactivity of the sympathetic nervous system, although the molecular basis of these 
findings have not been established, yet. It is therefore necessary to discern the intimate, 
molecular mechanisms determining both the susceptibility to certain diseases and a 
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pharmacotherapy of choice and with few side effects. From this point of view the 
pathogenic picture caused by the imbalance of the monoaminergic system becomes very 
important. Precise information regarding the different concentrations of monoamines in the 
cerebral tissue can bring considerable benefits to highlight the dynamics of these 
neuromediators. In addition, various therapies can change depending on the 
monoaminergic status for each individual.  
3.4 Aim of the study 
Based on these considerations, the researches conducted and presented in this paper were 
aimed to investigate the cerebral monoaminergic status of the adrenergic 
psychoneuroendocrine typology. Results were compared with the opposite 
psychoneuroendocrine type (type O) and with the intermediate, balanced, normal type 
(type N). 
The paper presents an experimental model, on mice, to investigate the possible correlations 
between the behavioral psychoneuroendocrine typology and the brain levels of 
noradrenaline (NA), dopamine (DA), serotonin (5-HT) and γ -amino butyric acid (GABA). 
We used two different experimental contexts: 
 correlations between the cerebral levels of the monoamines with the behavioral 
psychoneuroendocrine typology in basal state; 
 correlations between the cerebral levels of the monoamines with the behavioral 
psychoneuroendocrine typology after exposure to acute stress. 
4. Matherials and methods 
4.1 Animals 
Studies were conducted on 120 male, Albino Swiss mice, weighing 20-22 g. They were 
housed in a room and maintained at 25 ± 2ºC and 45-55% relative humidity, with an 
alternating 12h light-dark cycle. They had free access to food and water untill the morning 
of the experiment. All animals used in this study were maintained in facilities fully 
accreditated and the experiments described here were performed in compliance with the 
European Communities Council Directive of 24 November 1986 (86/609/EEC) and 
Ordinance No. 37 of the Romanian Government from 2nd February 2002. 
4.2 Identification of the murine behavior type 
Mice were divided in three behavioral groups, according to their reactivity to painful 
stimulus (endogenous analgesia): type A (associated with hypersensitivity to pain)  
and type B (“non-A”, the opposite type of behavior) which exhibits hypo-reactivity to 
pain. 
For the identification of the murine behavior type we used the hot-plate test (Ugo Basile 
apparatus). The plate was heated at 60 ºC and the animals were divided, based on their 
reactivity to painful stimulus (endogenous analgesia, expressed as jumping time off the heated 
plate), into three working groups: the adrenergic “A” type, the equilibrated, intermediate, 
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“N” type and the “O” type, according to Gauss normal distribution curve. The average 
value (M) of the jumping time off the plate was established. Mice that possessed a value of 
the jumping time of M ± 1SD were selected as intermediate, “N” type. Mice that possessed 
the value of the jumping time less than M – 1SD (<M – 1SD) were selected as adrenergic “A” 
type, while the jumping time of more than M + 1SD (>M + 1SD) were selected as the “non-
A” type (“O” type). 
Acute stress was induced to animals using the classical forced swimming test. (Petit-
Demouliere B.) 
4.3 The assessment of cerebral monoaminergic status 
Mice were sacrificed by decapitation and the whole brains were rapidly removed, weighed 
and kept at -80ºC until analyzed. Cerebral monoaminergic status (neuronal monoamines 
levels) within the behavioral model was evaluated by measuring the murine brain levels of 
noradrenaline (NA), dopamine (DA), serotonin (5-HT) using HPLC with UV detection, and 
γ-aminobutiric acid (GABA), using a fluorimetric assay. Results were expressed as μg 
neurotransmitter/mg wet tissue. 
4.4 Simultaneous, HPLC evaluation of endogenous NA, DA and 5-HT 
Samples were homogenized and deproteinized in 0.2M perchloric acid containing 100μM 
EDTA-Na2. The homogenate was left for 30min. to deproteinize. Then, the homogenate was 
centrifuged at 10,000×g for 15min at 0ºC (Janetzki K24 cooling centrifuge). After 
centrifugation, the supernatant was adjusted to pH=3.35 by adding 1M acetic acid. 20μl 
were injected into an HPLC reversed–phase system (VARIAN – PROSTAR) with a 
Chromsep-Inertsil 5 OSD2, 250x 4.6 mm column. The mobile phase consisted of 0.8 mM 
EDTA-Na2, 0.12M NaH2PO4 × H2O, 0.646g sodium heptane sulphonate and 17% methanol. 
Monoamines were detected simultaneously, using an UV detector (210nm). 
4.5 Determination of endogenous GABA concentrations 
Brain tissue samples were separately homogenized in 10 volumes of 0.01 M HCl using a 
glass homogenizer. The determination of endogenous GABA concentration is based on a 
fluorimetric assay that depends on the formation of a fluorescent product from the 
reaction between GABA and ninhydrin at alkaline pH and in the presence of glutamate. 
The reagents used in the assay were 0.05 M glutamic acid in 0.2 M sodium phosphate 
buffer, pH 6.4, 14 mM ninhydrin in 0.5M sodium carbonate buffer, pH 9.9-10 and copper 
tartrate reagent consisting of 1.6g Na2CO3, 329 mg tartric acid and 300 mg CuSO4 × 5H2O, 
all made up in 1 liter of distilled water. 0.25 ml of homogenate was diluted with 0.25 ml of 
0.01 M HCl and 0.5 ml of 10% trichloroacetic acid. This last reagent was used to 
precipitate the proteins. After the samples were centrifuged, 100 μl aliquots of the 
supernatant were added to 15 μl of glutamate solution and 200 μl of the ninhydrin 
solution. This mixture was incubated at 60ºC for 30 minutes and allowed to cool before 
the addition of 5 ml copper tartrate reagent. We also prepared two internal standards by 
adding to the samples of homogenate known amounts of GABA (50 μg and 100 μg GABA 
per sample) with the trichloroacetic acid. 
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5. Results and discussion 
5.1 Assessment of the basal neuronal concentrations of noradrenaline, dopamine, 
serotonin and gamma-amino butyric acid on the adrenergic and opioid types of 
behavior 
5.1.1 Distribution on psychoneuroendocrine murine groups   
The researches were conducted on a community consisting of 100 mice. In the first stage was 
established the individual reactivity to pain of the entire group (n = 100) using the hot plate 
test. There have been registered the results of the individual reaction to pain expressed by 
the times of jump. Based on these experimental data there could be noticed that for the 
collectivity of animals tested for reaction to pain, the individual values of the times of jump 
ranged between 4 and 60 seconds, the average time of jump (Jt medium) was of 36.02 sec, 
and the standard deviation (SD) value was of 13.9 sec.  
Depending on the individual reactivity to pain, the types of behavior were defined as 
follows:  
 the adrenergic type (A), hypersensitive: Jt = 4-22 sec;  
 normal, balanced type (N), normo-sensitive: Jt = 29-42 sec;  
 the opioid type (A), hipo-sensitive: Jt = 50-60 sec.  
The distribution of the animals from the researched collectivity, depending on the pain 
sensitivity is shown in Figure 1.  
 
Fig. 1. The distribution of animals (n = 100) according to their pain sensitivity 
The groups average values of the neuronal endogenous concentrations of noradrenaline 
(NA), dopamine (DA), serotonin (5HT) and GABA are shown in Table 1.  
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Behavior type 
Cerebral concentration of the studied neuromediators 
in the basal state 
(μg/ mg wet tissue) 
NA DA 5HT GABA 
A type 1.01±0.189 0.67±0.2 0.12±0.005 1.14 ± 0.5 
N type 1.04±0.11 1.02 ± 0.13 0.36 ± 0.09 0.70 ± 0.33 
O type 1.52±0.26 1.1±0.01 0.53±0.01 0.54 ± 0.18 
Table 1. The average values of the studied neuromediators, in basal state 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Examples of chromatograms corresponding to types A, N and O in basal state 
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Fig. 3. Examples of fluorescence spectra corresponding to the neuronal endogenous 
concentrations of GABA in type A (___), type N (___) and type O (___) 
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Fig. 4. The brain levels of the studied neuromediators, for the three murine behavioral types, 
in basal state 
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Fig. 5. Comparative assessement of the neuromediators neuronal concentrations studied, in 
brain, depending on the psychoneuroendocrine typology. Basal state 
The status of the three types of basal monoaminergic psychoneuroendocrine studied 
concentrations was assessed by quantifying the neuronal noradrenaline, dopamine, 
serotonin and γ-amino butyric acid. Analyzing the experimental results highlighted the 
following issues:  
 the neural dynamics of noradrenaline in basal state, has a maximum concentration in 
the opioid type (1.52 ± 0.26μg/mg wet tissue);  
 there is a positive correlation (Pearson correlation coefficient r = 0.957) between the 
jumping time (a physiological parameter that describes the behavior typology) and a 
cerebral biochemical marker, namely the concentration of noradrenaline; 
 both the adrenergic type and the balanced type releases much smaller amounts of 
noradrenaline, compared with type O (statistically significant): 1.01 ± 0.189μg/mg wet 
tissue, p <0.05(type A) and the 1.04 ± 0.11μg/mg wet tissue, p <0.05 (type N) (fig 5);  
 the neural dynamics of dopamine in basal state, has a maximum concentration in the 
balanced type (1.02 ± 0.13μg/mg wet tissue), the recorded values being significantly 
higher than those recorded for the type A (0.67 ± 0.2μg/mg wet tissue , p <0.01) and 
type O (1.1 ± 0.01μg/mg wet tissue, p <0.01);  
 the neural dynamics of serotonin in basal state, has a maximum concentration in the 
balanced type (0.36 ± 0.09μg/mg wet tissue), the recorded values being significantly 
higher compared with type O (0.53 ± 0.01μg/mg wet tissue, p <0.001), especially 
compared with type A (0.12 ± 0.005μg/mg wet tissue, p <0.05);  
  the adrenergic psychoneuroendocrine type has a much higher concentration of GABA 
(fig 5), statistically significant (1.14 ± 0.50 µg GABA/mg wet tissue) compared with both 
the opioid type (0.54 ± 0.18 µμmols GABA / mg wet tissue, p <0.01) and the 
intermediate type, balanced (0.70 ± 0.33 µμmols GABA / mg wet tissue, p <0.05).  
The GABA-ergic status varies inversely with the sensitivity to pain of the individuals from a 
population (Fig. 7), recording the maximum values for hypersensitive typology (Type A), 
Pearson correlation coeffient having a value of r = -0.9758. 
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It can be said therefore that the GABA-ergic transmission modulates, balances, in the basal 
state, the behavioral type "of warning", the adrenergic type.  
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Fig. 6. Correlation between the jumping time and NA concentration for the three behavioral 
types 
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Fig. 7. Correlation between the jumping time and GABA concentration for the three 
behavioral types 
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Fig. 8. Negative correlation between the basal neuronal concentrations of noradrenaline and 
γ-amino butyric acid , in basal state, for the the three murine behavioral types described (r = 
-0.9577) 
The comparative analysis of the followed parameters (painful sensitivity - physiological 
parameter, expression of the psychoneuroendocrine typology and the neuronal 
concentrations of some biologically active monoamines - molecular biochemical markers) 
was able to reveal the following:  
 in basal state, the adrenergic type (hypersensitive to painful stimuli) is not highlighted 
by a extremely high monoamine-ergic status, but is revealed as a very well balanced 
type, in this regard (high concentrations of both noradrenaline and γ-amino butyric 
acid);  
 the opioid type, hipo-sensitive to pain, has also, unexpectedly, in basal state, the highest 
concentrations of noradrenaline in neurons, and large amounts of serotonin;  
 in basal state, the balanced type releases the most large amounts of dopamine and 
serotonin.  
5.2 Assessment of the neuronal concentrations of noradrenaline, dopamine, 
serotonin and gamma-amino butyric acid on A adrenergic and opioid types of 
behavior after acute stress 
5.2.1 Distribution on psychoneuroendocrine murine groups 
The researches were conducted on a community consisting of 100 mice. In the first stage was 
followed the individual reactivity to pain of the entire group (n = 100) using the hot plate 
test. There have been registered the results of the individual reaction to pain expressed by 
the times of jump. Based on these experimental data there could be noticed that for the 
collectivity of animals tested for reaction to pain, the individual values of the times of jump 
ranged between 4 and 60 seconds, the medium time of jump (average medium Jt) was of 36.04 sec 
and the standard deviation (SD) value was of 15.85 sec.  
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Depending on the individual reactivity to pain, the types of behavior were defined as 
follows:  
 the adrenergic type (A), hypersensitive: Jt = 4-20 sec;  
 the normal, balanced type (N), normo-sensible: Jt = 29-42 sec;  
 the opioid type (A), hipo-sensible: Jt = 52-60 sec.  
 
Fig. 9. Distribution of animals (n = 100) according to pain sensitivity 
The acute stress was induced through the forced swimming test, the test of "desperation". 
After the 6 minutes of forced swim, each animal was sacrificed, the cerebral tissue was 
isolated and the biological material was processed to determine the concentration of the 
neuromediators NA, DA and 5HT by HPLC with UV detection.  
 
Behavior type 
Cerebral concentration of the studied neuromediators after 
inducing acute stress 
(μg/ mg wet tissue) 
NA DA 5HT GABA 
A type 3.41 ± 1.14 0.13 ± 0.03 0.12 ± 0.05 1.55 ± 0.77 
N type 1.59 ± 0.24 0.32 ± 0.12 0.45 ± 0.13 1.52 ± 0.55 
O type 1.55 ± 0.13 0.25 ± 0.05 0.47 ± 0.1 3.15 ± 0 .68 
Table 2. The average values of the studied neuromediators, after acute stress 
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The brain levels of the studied neuromediators, for the three murine 
behavioral types, after acute stress
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Fig. 10. The brain levels of the studied neuromediators, for the three murine behavioral 
types, after acute stress 
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Fig. 11. Comparative assessement of the neuromediators neuronal concentrations studied, in 
brain, depending on the psychoneuroendocrine typology. Acute stress 
The assessment of the monoaminergic status of the three psychoneuroendocrine types after 
acute stress highlights the following:  
 in acute stress, the adrenergic type releases, in neurons, the largest amounts of 
noradrenaline (statistically significant) (3.41 ± 1.14μg/mg wet tissue) compared with 
type N (1.59 ± 0.24μg / mg wet tissue), but especially compared with type O (1.55 ± 
0.13μg/mg wet tissue, p <0.01);  
 type A it also developes the lowest amounts of γ-amino butyric acid , its concentrations 
being negatively correlated with those of noradrenaline (r=-0.9345, fig.y); 
 the balanced type releases, in acute stress, the highest quantities of dopamine, the 
dynamic of this neuromediators varying in the following order: type A (0.13 ± 
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0.03μg/mg wet tissue, p <0.000001) <type O (0.25 ± 0.05μg/mg wet tissue , p <0.001) 
<type N (0.32 ± 0.12μg/mg wet tissue);  
 the neuronal dynamics of serotonin, in stress state, has a maximum concentration in the 
opioid type (0.47 ± 0.1μg/mg wet tissue), the recorded values were significantly higher 
compared with type A (0.12 ± 0.05μg/mg wet tissue; p <0.01); the balanced type, in 
turn, revealed higher values of serotonin concentration (0.45 ± 0.13μg/mg wet tissue) 
compared with type A.  
  the opioid psychoneuroendocrine type has a much higher concentrations of GABA, 
statistically significant (3.15 ± 0,68 μg GABA/mg wet tissue) compared with both 
adrenergic type (1.55 ± 0.77 μg GABA/mg wet tissue, p <0.001) and the intermediate balanced 
type (1.52 ± 0.55 μ/mg gwet tissue, p <0.001).  
 our data showed a positive correlation (r = 0.9584) between the neuronal levels of 
serotonin and GABA after inducing acute stress in the O type of behavior. (fig. 13). 
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Fig. 12. Negative correlation between neuronal concentrations of of noradrenaline and γ-
amino butyric acid , for the A type, after acute stress 
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Fig. 13. Positive correlation between neuronal concentrations of of serotonin and γ-amino 
butyric acid , for the O type, after acute stress 
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After the induction of acute stress, the two followed parameters (painful sensitivity - 
physiological parameter, expression of the psychoneuroendocrine typology, respectively, 
the status of the monoaminergic-molecular biochemical marker) revealed some notable 
observations:  
 in acute stress, the adrenergic type biosynthesis  and releases the largest quantities of 
noradrenaline;  
 the opioid type releases, in stress, gamma-amino butyric acid and serotonin. 
The comparative assessment of the dynamics of the neuronal concentrations of 
noradrenaline (NA), dopamine (DA), serotonin (5-HT) and γ-amino butyric acid (GABA) in 
basal state and after acute stress, is shown in Figures 14-17.  
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Fig. 14. Dinamics of brain concentrations of noradrenaline in basal state and after acute 
stress, for the studied behavioral typologies 
 
0
0.2
0.4
0.6
0.8
1
1.2
Cerebral dopamine 
concentration μg/mg 
wet tissue
A type N type O type
basal state
acute stress
basal state
acute stress
 
Fig. 15. Dinamics of brain concentrations of dopamine in basal state and after acute stress, 
for the studied behavioral typologies 
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Fig. 16. Dinamics of brain concentrations of serotonin in basal state and after acute stress, for 
the studied behavioral typologies 
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Fig. 17. Dinamics of brain concentrations of γ-amino butyric acid  in basal state and after 
acute stress, for the studied behavioral typologies 
6. Conclusion 
The experimental study presented proves, once again, the great biological variability and 
brings new information on the molecular mechanisms that maintain the homeostasis of the 
central nervous system. From this point of view, the psychoneuroendocrine typology 
reveals itself as a major factor of the pharmacological responses to drugs with action on the 
monoaminergic transmission.  
The different therapies might suffer changes (might be improved) to optimize the 
pharmacological response by the criterion of the psychoneuroendocrine typology. The 
clinical observations reported in the literature, pathologies associated to typologies and the 
pharmacologic response to various drugs possess a high degree of subjectivity, requiring 
intimate, molecular discerning mechanisms which cause both susceptibility to various 
diseases, and appropriate therapy.  
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From this point of view, the researches presented reveal molecular information, which can 
maintain and complete the clinical and experimental data reported in the literature. Thus, 
the type A, characterized by a behavioral point of view by alert, rush, speed, hostility, 
aggressiveness, is proving extremely balanced in terms of basal neural mechanisms. The 
basal monoaminergic tone of type A is stable and maintained in moderate limits (high levels 
of noradrenaline, together with high levels of γ-amino butyric acid–the main inhibitory 
neuromediator of the CNS). We can say that, in the basal state, the adrenergic type, though 
alert and active in terms of behavior, is balanced and protected at the molecular level by the 
inhibitory GABA-ergic mechanisms. 
The intervention of the stress factors distorts, however, in the adrenergic type, these balance 
mechanisms (activating/inhibiting), against the inhibition mechanisms (protection), by 
releasing extremely large quantities of noradrenaline, together with low amounts of γ-amino 
butyric acid. 
This could be one of the possible observations of molecular pharmacology which prones the 
A type vulnerability to stress (with the pathological consequences reported in literature).  
In contrast to the adrenergic type, the O type of behavior offers surprising observations. It 
developed high neuronal concentrations of NA in basal state (much higher than for type A), 
but with no psychosomatic effect. It seems that the opioid type does not use important 
cellular concentrations of noradrenaline, its molecular mechanisms being modulated, 
probably by endogenous opioids. In stress, it is modulated (beside the endogenous opiates) 
through serotoninergic pathways (high serotonin levels) together with an extremely high 
GABA-ergic status.  In addition, the acute stress does not lead, for type O, to substantial 
fluctuations in the amount of cerebral noradrenaline, compared with basal condition. It is 
quite possible for the opioid psychoneuroendocrine type to be behavioral modulated, by an 
interrelation between the endogenous opioid system with the triptaminergic 
(serotoninergic) system.  
These experimental data lead, naturally, to the following question: why some individuals 
cellulary use more noradrenaline, while others use endogenous opioids? Is there, perhaps, a 
"preference" of the neurons for certain neuromediator? A possible answer might be found in 
modern theories of the substrate receptors resistance (e.g. the assumption of the resistance of 
the insulin receptors, which explains the etiopathology of type 2 diabetes). Thus, it is quite 
possible that the adrenergic receptors of type O are resistant to noradrenaline, while the 
opioid receptors of type A are resistant to endogenous opioids.  
Our hypothesis is sustained by the researchers of the serotonin type of behavior. by using 
the modern technology of the positron emission tomography (TEP), they have shown that 
these individuals framed by questionnaires of personality in the serotoninergic typology, 
have a large number of 5HT1A receptors. Extrapolating this observation to types A and O, it 
might appear the hypothesis of the existence of a significant variation of the adrenergic 
receptor density, respectively, opioids among the individuals of a population.  
The neural dynamics of the monoaminergic mediators for extreme typologies (A and O) is 
confirmed by the results of the intermediate, balanced type, which biosynthesizes and 
releases, in stress, all the researched neuromediators, in large quantities. There is also a 
special preference of the intermediate N type for using dopamine as a biomolecule of stress.  
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The paper provides molecular evidences that support and argue the theory of the 
pharmacological variability, due to the psychoneuroendocrine typology (as a part of the 
biological variability), and bipolar disorder is included within. A review seeking to identify 
the more consistent findings suggested that there are several genes involved in the 
development of bipolar disorder (Serretti A., 2008), such as those for serotonin (SLC6A4 and 
TPH2), dopamine (DRD4 and SLC6A3) and excitatory neuromediators (DAOA and 
DTNBP1). There is also a the theory asserting that people developping bipolar disorder 
experience a series of stressful events, each of which lowers the threshold at which mood 
changes occur (Brian Koehler et al). There are also reported evidences of neuronal 
abnormalities in bipolar disorder due to stress. Published clinical studies, reported the 
prevalence of bipolar disorder within the adrenergic behavioral type. 
In this sense, the imbalances of the monoaminergic systems, which may lead and/or sustain 
bipolar disorder  require, certainly, an individualized pharmacotherapy on the criterion of 
the psychoneuroendocrine typology.  
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